stockrowBioXcel Therapeutics, Inc. (BTAIQ) vs PainReform Ltd. (PRFX)
- BioXcel Therapeutics, Inc. BTAIQ 0.01 0.00%
- PainReform Ltd. PRFX 0.82 +7.89%
BioXcel Therapeutics, Inc. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. BioXcel Therapeutics, Inc. and PainReform Ltd. are of similar size ($2.3M and $2.3M). PainReform Ltd. has the higher net margin (0.00% vs −9,549.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, BioXcel Therapeutics, Inc. leads on 6 and PainReform Ltd. on 6.
Valuation
| Metric | BTAIQ | PRFX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.55 |
| P/S | 0.41 | n/m | 2.08 |
| P/B | n/m | 0.00 | 1.79 |
| Price to free cash flow | n/m | n/m | 16.29 |
| EV/EBITDA | n/m | 0.97 | 12.22 |
| EV/Sales | 227.51 | n/m | 2.87 |
| Earnings yield | (37,900.00%) | (156,798.70%) | (15.94%) |
| Free cash flow yield | (16,806.60%) | (101,853.01%) | 0.00% |
Profitability
| Metric | BTAIQ | PRFX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.10% | 0.00% | 53.51% |
| Operating margin | (6,054.72%) | 0.00% | 0.00% |
| Net margin | (9,549.87%) | 0.00% | (2.45%) |
| Free cash flow margin | (6,860.38%) | 0.00% | 0.00% |
| Return on equity | 63.52% | 0.00% | (0.80%) |
| Return on assets | (259.62%) | 0.00% | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack